O
ASND icon

OppenheimerFunds’s Ascendis Pharma A/S ASND Stock Holding History

OppenheimerFunds’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$50.2M Sell
426,318
-1,022
-0.2% -$89.5K 0.06% 311
2018
Q4 		$26.8M Sell
427,340
-760
-0.2% -$47.8K 0.04% 437
2018
Q3 		$30.3M Sell
428,100
-90
-0% -$6.2K 0.04% 477
2018
Q2 		$28.5M Buy
428,190
+510
+0.1% +$33.5K 0.03% 489
2018
Q1 		$28M Buy
427,680
+130,540
+44% +$7.34M 0.03% 475
2017
Q4 		$11.9M Sell
297,140
-220
-0.1% -$8K 0.01% 716
2017
Q3 		$10.8M Sell
297,360
-270
-0.1% -$7.75K 0.01% 729
2017
Q2 		$8.26M Hold
297,630
– – 0.01% 770
2017
Q1 		$8.33M Buy
+297,630
New +$7.52M 0.01% 793

Other funds holding ASND

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OppenheimerFunds's ASND Position: Q1 2019 in Review

OppenheimerFunds reduced its Ascendis Pharma A/S (ASND) stake by 0.24% in Q1 2019, selling an estimated $89.5K and leaving 426,318 shares worth $50.2M. The position accounts for 0.06% of the portfolio, ranked #311.

OppenheimerFunds first reported a position in ASND in Q1 2017 and has held it in 9 quarters since. 138 funds tracked by Wall St. Rank hold ASND as of Q1 2019.

  • OppenheimerFunds held 426,318 shares of Ascendis Pharma A/S worth $50.2M as of Q1 2019.
  • OppenheimerFunds sold 1,022 Ascendis Pharma A/S shares in Q1 2019, an estimated $89.5K.
  • Ascendis Pharma A/S made up 0.06% of OppenheimerFunds's portfolio in Q1 2019, its #311 holding.
  • OppenheimerFunds first reported a position in Ascendis Pharma A/S in Q1 2017 and has held it in 9 quarters since.
  • 138 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.